These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32001622)

  • 1. Exercise and myocardial injury in hypertrophic cardiomyopathy.
    Cramer GE; Gommans DHF; Dieker HJ; Michels M; Verheugt F; de Boer MJ; Bakker J; Fouraux MA; Timmermans J; Kofflard M; Brouwer M
    Heart; 2020 Aug; 106(15):1169-1175. PubMed ID: 32001622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy.
    Gommans DF; Cramer GE; Bakker J; Michels M; Dieker HJ; Timmermans J; Fouraux MA; Marcelis CL; Verheugt FW; Brouwer MA; Kofflard MJ
    Heart; 2017 Feb; 103(4):293-299. PubMed ID: 27506680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging in hypertrophic cardiomyopathy: association with high T2-weighted signal intensity in addition to late gadolinium enhancement.
    Shi RY; An DA; Chen BH; Wu R; Du L; Jiang M; Xu JR; Wu LM
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2229-2238. PubMed ID: 32666169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy.
    Gommans DHF; Cramer GE; Bakker J; Dieker HJ; Michels M; Fouraux MA; Marcelis CLM; Verheugt FWA; Timmermans J; Brouwer MA; Kofflard MJM
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):113-120. PubMed ID: 29063221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
    J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy.
    Hasler S; Manka R; Greutmann M; Gämperli O; Schmied C; Tanner FC; Biaggi P; Lüscher TF; Keller DI; Gruner C
    Swiss Med Wkly; 2016; 146():w14285. PubMed ID: 26999566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy.
    Gastl M; Gruner C; Labucay K; Gotschy A; Von Spiczak J; Polacin M; Boenner F; Kelm M; Ruschitzka F; Alkadhi H; Kozerke S; Manka R
    Open Heart; 2020; 7(1):e001152. PubMed ID: 32201584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy.
    Liao H; Tan HC; Wang Z; Chen X; He Y; He S
    BMC Cardiovasc Disord; 2021 Jul; 21(1):325. PubMed ID: 34217206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Jenab Y; Pourjafari M; Darabi F; Boroumand MA; Zoroufian A; Jalali A
    J Cardiol; 2014 Feb; 63(2):140-4. PubMed ID: 24011925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Kawasaki T; Sakai C; Harimoto K; Yamano M; Miki S; Kamitani T
    Am J Cardiol; 2013 Sep; 112(6):867-72. PubMed ID: 23746480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Extensive Myocardial Fibrosis in Nonhigh Risk Patients With Hypertrophic Cardiomyopathy.
    Gommans DHF; Cramer GE; Fouraux MA; Bakker J; Michels M; Dieker HJ; Timmermans J; Marcelis CLM; Verheugt FWA; de Boer MJ; Kofflard MJM; de Boer RA; Brouwer MA
    Am J Cardiol; 2018 Aug; 122(3):483-489. PubMed ID: 30201111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin I and T as prognostic markers in cats with hypertrophic cardiomyopathy.
    Langhorn R; Tarnow I; Willesen JL; Kjelgaard-Hansen M; Skovgaard IM; Koch J
    J Vet Intern Med; 2014; 28(5):1485-91. PubMed ID: 25056593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy.
    Chen S; Huang L; Zhang Q; Wang J; Chen Y
    Medicine (Baltimore); 2020 Jun; 99(23):e20134. PubMed ID: 32501969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk.
    Cramer G; Bakker J; Gommans F; Brouwer M; Kurvers M; Fouraux M; Verheugt F; Kofflard M
    Am J Cardiol; 2014 Apr; 113(7):1240-5. PubMed ID: 24513467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of serum cardiac troponins T and I to predict cardiac molecular changes and cardiac damage in patients with hypertrophic cardiomyopathy.
    Okamoto R; Hirashiki A; Cheng XW; Yamada T; Shimazu S; Shinoda N; Okumura T; Takeshita K; Bando Y; Kondo T; Murohara T
    Int Heart J; 2013; 54(4):202-6. PubMed ID: 23924931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
    Gawor M; Śpiewak M; Kubik A; Wróbel A; Lutyńska A; Marczak M; Grzybowski J
    Biomarkers; 2018 Nov; 23(7):676-682. PubMed ID: 29737871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy.
    Moreno V; Hernández-Romero D; Vilchez JA; García-Honrubia A; Cambronero F; Casas T; González J; Martínez P; Climent V; de la Morena G; Valdés M; Marín F
    J Card Fail; 2010 Dec; 16(12):950-6. PubMed ID: 21111984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.